Phase III Randomized Trial Evaluating Tilsotolimod in Combination with Ipilimumab Versus Ipilimumab Alone in Patients with Advanced Refractory Melanoma (ILLUMINATE 301).
JOURNAL OF CLINICAL ONCOLOGY(2024)
关键词
261-492-3532-2370-7650-2700,283-232,261-492-3532-2373,281-5277-2560,281-318-9082,47,47,12,38092-29187
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要